1. Home
  2. OVID vs HEQ Comparison

OVID vs HEQ Comparison

Compare OVID & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Hedged Equity & Income Fund of Beneficial Interest

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$11.50

Market Cap

139.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVID
HEQ
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
117.5M
139.0M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
OVID
HEQ
Price
$1.62
$11.50
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$3.40
N/A
AVG Volume (30 Days)
1.1M
45.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
3.90
N/A
EPS
N/A
N/A
Revenue
$566,000.00
N/A
Revenue This Year
$1,077.56
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$9.23
52 Week High
$2.01
$11.58

Technical Indicators

Market Signals
Indicator
OVID
HEQ
Relative Strength Index (RSI) 53.68 66.82
Support Level $1.43 $10.55
Resistance Level $1.70 N/A
Average True Range (ATR) 0.10 0.08
MACD 0.02 0.00
Stochastic Oscillator 82.26 71.54

Price Performance

Historical Comparison
OVID
HEQ

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: